Delivered August 27, 2020. Contributor: Radovan V.
To identify privately-held "unicorn" companies whose shares might be currently selling at a discount in the secondary market because of COVID-19, but that are likely to experience a significant recovery in 1-2 years, after the pandemic subsides.
Sixty three out of 161 provided companies have been analyzed during the first hour of research. The findings are presented in the attached spreadsheet.
Each analyzed company has been labeled either "Yes", "No", or "Possibly" in column V of the spreadsheet, depending on a subjective analysis of its potential fit to the outlined investing strategy (investing in private companies that are experiencing difficulties in the short-term because of COVID-19, but that are expected to recover significantly after the pandemic passes).
The reasons for choosing a particular label, as well as additional notes, have been provided in column W of the attached spreadsheet. Please note that the comments are based on a subjective guess backed by intuition, experience, and basic research, as instructed.
Some companies have been marked with "???" in column V. Additional research is required to determine the potential effects of COVID-19 on the performance of these companies.
Only the project owner can select the next research path.